Glucose testing and insufficient follow-up of abnormal results: a cohort study

被引:14
作者
Kern, Lisa M. [1 ]
Callahan, Mark A.
Brillon, David J.
Vargas, Maryelena
Mushlin, Alvin I.
机构
[1] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Med, New York, NY USA
[3] New York Presbyterian Hosp, New York, NY USA
[4] Columbia Univ, Sch Nursing, New York, NY USA
关键词
Primary Care Physician; American Diabetes Association; Impaired Fasting Glucose; Initial Visit; Abnormal Result;
D O I
10.1186/1472-6963-6-87
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: More than 6 million Americans have undiagnosed diabetes. Several national organizations endorse screening for diabetes by physicians, but actual practice is poorly understood. Our objectives were to measure the rate, the predictors and the results of glucose testing in primary care, including rates of follow-up for abnormal values. Methods: We conducted a retrospective cohort study of 301 randomly selected patients with no known diabetes who received care at a large academic general internal medicine practice in New York City. Using medical records, we collected patients' baseline characteristics in 1999 and followed patients through the end of 2002 for all glucose tests ordered. We used multivariate logistic regression to measure associations between diabetes risk factors and the odds of glucose testing. Results: Three-fourths of patients (78%) had at least 1 glucose test ordered. Patient age (>= 45 vs. <45 years), non-white ethnicity, family history of diabetes and having more primary care visits were each independently associated with having at least 1 glucose test ordered (p < 0.05), whereas hypertension and hyperlipidemia were not. Fewer than half of abnormal glucose values were followed up by the patients' physicians. Conclusion: Although screening for diabetes appears to be common and informed by diabetes risk factors, abnormal values are frequently not followed up. Interventions are needed to trigger identification and further evaluation of abnormal glucose tests.
引用
收藏
页数:6
相关论文
共 16 条
[1]  
*AM DIAB ASS, 1998, DIABETES CARE, V21, pS320
[2]  
American Diabetes Association, 2004, DIABETES CARE S1, V27, pS11, DOI DOI 10.2337/DIACARE.27.2007.S11
[3]   Screening for type 2 diabetes mellitus in adults: Recommendations and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, P ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Sin, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (03) :212-214
[4]   Tools for analyzing multiple imputed datasets [J].
Carlin, John B. ;
Li, Ning ;
Greenwood, Philip ;
Coffey, Carolyn .
STATA JOURNAL, 2003, 3 (03) :226-244
[5]   FREQUENCY AND DETERMINANTS OF SCREENING FOR DIABETES IN THE US [J].
COWIE, CC ;
HARRIS, MI ;
EBERHARDT, MS .
DIABETES CARE, 1994, 17 (10) :1158-1163
[6]   POWER AND SAMPLE-SIZE CALCULATIONS - A REVIEW AND COMPUTER-PROGRAM [J].
DUPONT, WD ;
PLUMMER, WD .
CONTROLLED CLINICAL TRIALS, 1990, 11 (02) :116-128
[7]   Opportunistic screening for diabetes in routine clinical practice [J].
Ealovega, MW ;
Tabaei, BP ;
Brandle, M ;
Burke, R ;
Herman, WH .
DIABETES CARE, 2004, 27 (01) :9-12
[8]  
Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757
[9]  
Gavin JR, 1999, DIABETES CARE, V22, pS5
[10]   Screening adults for type 2 diabetes: A review of the evidence for the US Preventive Services Task Force [J].
Harris, R ;
Donahue, K ;
Rathore, SS ;
Frame, P ;
Woolf, SH ;
Lohr, KN .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (03) :215-229